Peptide directory

Find a peptide

Public profiles inside a larger governed registry

Search by peptide name, brand, or research code. Open a full evidence profile or the published sources available for a record still in development. Source publication does not mean a completed scientific appraisal.

The registry is an expanding catalog, not a complete list of every peptide. A missing public result does not mean no research exists.

There are 51 full evidence profiles. "Complete profiles" is a stricter subset of them (12): Full profiles that pass every blocking completion check (published sources, a documented review of a source, chemistry, two regulatory records, linked conclusions and the narrative sections). A full evidence profile that is not yet complete has simply not passed every one of those checks.

Published profiles

Search profiles and sources

Compare peptides side by side →
Refine by category
Category

354 peptide records (0 full evidence profiles, 354 source-only records)

  • Venom-derived peptide toxin

    Iberiotoxin

    Source-only record4 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    4 published source records. Source publication does not imply scientific appraisal.

    Open sources for Iberiotoxin →
  • Bradykinin B2 receptor antagonist peptide

    Icatibant

    Source-only record5 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    5 published source records. Source publication does not imply scientific appraisal.

    Open sources for Icatibant →
  • IGF-1 analog

    IGF-1 LR3

    Source-only record5 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    5 published source records. Source publication does not imply scientific appraisal.

    Open sources for IGF-1 LR3 →
  • Antimicrobial peptide

    Indolicidin

    Source-only record4 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    4 published source records. Source publication does not imply scientific appraisal.

    Open sources for Indolicidin →
  • Endogenous glycoprotein hormone

    Inhibin A

    Source-only record2 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    2 published source records. Source publication does not imply scientific appraisal.

    Open sources for Inhibin A →
  • Endogenous glycoprotein hormone

    Inhibin B

    Source-only record2 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    2 published source records. Source publication does not imply scientific appraisal.

    Open sources for Inhibin B →
  • Peptide hormone

    Insulin

    Source-only record6 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    6 published source records. Source publication does not imply scientific appraisal.

    Open sources for Insulin →
  • Insulin peptide chain

    Insulin A chain

    Source-only record1 published sourceno study appraisals

    Published sources available; full evidence profile in development.

    1 published source records. Source publication does not imply scientific appraisal.

    Open sources for Insulin A chain →
  • Insulin analog

    Insulin aspart

    Source-only record2 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    2 published source records. Source publication does not imply scientific appraisal.

    Open sources for Insulin aspart →
  • Insulin peptide chain

    Insulin B chain

    Source-only record1 published sourceno study appraisals

    Published sources available; full evidence profile in development.

    1 published source records. Source publication does not imply scientific appraisal.

    Open sources for Insulin B chain →
  • Insulin analog

    Insulin degludec

    Source-only record2 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    2 published source records. Source publication does not imply scientific appraisal.

    Open sources for Insulin degludec →
  • Insulin analog

    Insulin detemir

    Source-only record3 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    3 published source records. Source publication does not imply scientific appraisal.

    Open sources for Insulin detemir →
  • Insulin analog

    Insulin glargine

    Source-only record3 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    3 published source records. Source publication does not imply scientific appraisal.

    Open sources for Insulin glargine →
  • Long-acting insulin analog

    Insulin icodec

    Source-only record2 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    2 published source records. Source publication does not imply scientific appraisal.

    Open sources for Insulin icodec →
  • Insulin analog

    Insulin lispro

    Source-only record2 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    2 published source records. Source publication does not imply scientific appraisal.

    Open sources for Insulin lispro →
How the public directory relates to the 501-record Master Registry

master registry transparency

501 master records, with governance status shown explicitly

WPF-MASTER-REGISTRY-TRANSPARENCY-1.0
501
Master records
467
Governed records
34
Review-deferred
458
Eligible for literature search
9
Governed comparators

The master registry has 467 governed identities from 501 records. 34 remain review-gated. Nine governed records are scientific comparators, leaving 458 peptide identities in the literature-search cohort (identities whose published literature WPF searches for; it does not refer to obtaining or buying any product). Database reconciliation is a separate step. The 51 profiles shown on this directory are a represented public-profile subset, not the size of the master registry. All 51 public profiles on this render reconcile to governed peptide identities in that registry; unknown, duplicate, deferred, or comparator identities fail closed instead of appearing publicly.

Which number counts what

  • 501 master records: the known registry of peptide and comparator identities (a catalog, never assumed complete).
  • 405 directory records in the search above: 51 full evidence profiles plus 354 source-only records (identities with published, verified sources but no full profile). The 23 result pages hold 18 records each and are counted from this same list.
  • 51 full evidence profiles: the profiles in the JSON export and the structured data on this page.
  • The observation form’s peptide selector uses a separate, more permissive list of identities that can be reported on; it is not the directory and not the evidence corpus.
Explore the full Master Registry →
What the profile status labels mean

Evidence, chemistry, and regulatory counts include only records that crossed the relevant public-publication gate. A zero means none published in that lane—not that nothing is known. “No governed record published” is a publication-state disclosure; internal or pending material may exist without appearing in public counts. Source verification, editorial publication, and accountable scientific appraisal are distinct states; a source count alone does not approve a scientific conclusion.

Recently updated public records

When each public profile record was last changed — not clinical or scientific activity.